Fill out the form to see if you qualify.
GI Alliance is offering a clinical research study assessing the safety and effectiveness of an investigational medicine for Patients with Moderately to Severely Active Ulcerative Colitis.
There are other criteria that you will need to meet to qualify, which the study team will discuss with you.
The investigational study drug in this study is:
Please note: you will not qualify for this study if you have any of the following: severe extensive colitis; diagnosis of Crohn's disease (CD) or indeterminate colitis or the presence or history of a fistula consistent with CD; diagnosis of microscopic colitis, ischemic colitis, or infectious colitis. Please still complete a form, as we have other clinical trials that are actively recruiting.